ONE MORE STEP FOR MEDICINAL MARIJUANA NY TIMES NORMAN C KAPLAN
SEPT. 6, 1983
As printed in the New York Times and cited in the US Congressional Record by Congressman Louis Stokes (D21-Ohio) in 1983:
NY TIMES Archives | 1983
ONE MORE STEP FOR MEDICINAL MARIJUANA
SEPT. 6, 1983
About the Archive
This is a digitized version of an article from The Times’s print archive, before the start of online publication in 1996. To preserve these articles as they originally appeared, The Times does not alter, edit or update them.
To the Editor:
As a cancer researcher who has worked with the marijuana derivative Delta-9-Tetrahydrocannabinol for the past five years, both in its anti- cancer properties and in its anti-nausea properties for patients receiving cancer chemotherapy, I applaud your Aug. 27 editorial ''Marijuana and Medicine.''
A recent computer search of the medical literature revealed that over 50 articles on the therapeutic uses of the derivative and its analogues were published in the last three years. I have often commented on the tragic circumstances that in the past allowed this drug with tremendous medical potential to be readily available illegally to the individual on the street while it was difficult, nigh impossible, for the person suffering the ravages of cancer and chemotherapy to obtain.
Nevertheless, both the National Cancer Institute and the National Institute on Drug Abuse have made every effort in recent years to make Delta-9-Tetrahydrocannabinol capsules (Schedule I) available free to those suffering with cancer, and to make it available to researchers like myself working with scientific protocols acceptable to research committees within the state and Federal establishment. What is needed, as you state, is for the Food and Drug Administration and the Drug Enforcement Administration, under the urging of Congress, the scientific and medical community and the public, to move therapeutic Delta-9-Tetrahydrocannabinol from Schedule I (Investigational Experimental Substance) to Schedule II (Controlled Narcotic), which would enable any licensed oncologist, surgeon, opthalmologist, psychiatrist or other physician to prescribe it without excessive regulation or fear of legal liability for use of an ''experimental'' pharmaceutical. For responsible medical researchers, the substance has been and remains available; the problem is to ease the bureaucratic tangle that makes it difficult for physicians to order it and supply it to their patients. NORMAN CHARLES KAPLAN Shaker Heights, Ohio, Aug. 27, 1983
The writer is president of Calcol Inc., a medical and scientific research and consulting firm.
????? ????
??.???
NORMAN C KAPLAN
(CALCOL INC.(CLCL-OTC)
MALIBU-COLA BEVERAGE CO. LTD.
BEIJING KULONG ENERGY TRADING CO. LTD.
KULONG ENERGY BEVERAGE COMPANY INC.
FACEBOOK: NORMAN KAPLAN, CALCOL INC.,KULONG ENERGY BEVERAGE
COMPANY INC.
PO BOX 22228
BEACHWOOD OHIO 44122
AI
